Related Experiment Video
Updated: Oct 28, 2025

Facile Preparation of 4-Substituted Quinazoline Derivatives
Published on: February 15, 2016
8-Hydroxyquinolin-2(1H)-one analogues as potential β2-agonists: Design, synthesis and activity study
Gang Xing1, Zhengxing Zhi1, Ce Yi1
1Department of Medicinal Chemistry, School of Pharmaceutical Engineering, Shenyang Pharmaceutical University, Shenyang, 110016, China; Key Laboratory of Structure-Based Drug Design and Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang, 110016, China.
New 8-hydroxyquinolin-2(1H)-one analogues, B05 and C08, show potent and selective beta2-agonistic activity. These compounds demonstrate potential as bronchodilators for chronic respiratory diseases.
Area of Science:
- Medicinal Chemistry
- Pharmacology
- Respiratory Medicine
Background:
- Beta2-agonists are crucial bronchodilators for chronic respiratory diseases, acting via plasmalemmal beta2-adrenoceptors to increase cAMP.
- Development of novel, potent, and selective beta2-agonists remains an important therapeutic goal.
Purpose of the Study:
- To design, synthesize, and evaluate novel 8-hydroxyquinolin-2(1H)-one analogues for beta2-agonistic activity.
- To identify compounds with potential for treating chronic respiratory diseases.
Main Methods:
- Synthesis of 8-hydroxyquinolin-2(1H)-one analogues.
- Cellular cAMP assay to measure beta2-agonistic activity.
- Assessment of smooth muscle relaxant actions in isolated guinea pig tracheal strips.
Main Results:
- Compounds B05 and C08 exhibited potent (EC50 < 20 pM) and selective beta2-agonistic activity.
- B05 and C08 acted as partial beta2-agonists in non-overexpressed HEK293 cells.
- These compounds demonstrated rapid smooth muscle relaxation with a long duration of action.
Conclusions:
- B05 and C08 are identified as potent and selective beta2-agonists.
- The novel analogues show promise for the treatment of chronic respiratory diseases due to their pharmacological profile.
More Related Videos
09:39Drug-induced Sensitization of Adenylyl Cyclase: Assay Streamlining and Miniaturization for Small Molecule and siRNA Screening Applications
Published on: January 27, 2014
04:15Author Spotlight: Development of a Method for Identifying Small Molecular Antagonists of β2 Integrin Activation
Published on: February 2, 2024
Related Concept Videos
Adrenergic Agonists: Chemistry and Structure-Activity Relationship
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
Adrenergic Antagonists: Chemistry and Classification of β-Receptor Blockers
Adrenergic Antagonists: Chemistry and Classification of ɑ-Receptor Blockers
Nonselective α-blockers: Nonselective α-blockers contain haloalkylamine or imidazoline...
Cholinergic Antagonists: Chemistry and Structure-Activity Relationship
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...